Delivery Order SPE2DB24D1021-SPE2DB25FEYSZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,788.86 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Exforge 10-160 mg tablets (30-count packaging). This is a firm fixed-price delivery order with a completion date of May 13, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Exforge 5-320 mg tablets (30-count units) with a ceiling value of $11,807.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $40,865.39 to AmerisourceBergen Drug Corp for Exforge 5-160 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 11, 2025. The award was issued on August 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Exforge is a combination antihypertensive medication used to treat high blood pressure,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Exforge 10-320 mg tablets (30-count units) with a contract ceiling value of $18,372.83. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999.99 billion ceiling...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,145.66 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement. The place of performance is listed as Conshohocken, Pennsylvania, which coincides with AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,078.23. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the same location designated as...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,600.01 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count packaging) under a firm fixed-price contract. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYSZDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 17, 2025, for Exforge 5-320 mg tablets (30-count units) valued at $2,867.33. This competitive award, issued without set-aside designation, represents a firm fixed-price contract with an ultimate completion date of July 18, 2025. The place of performance is located at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The IDC serves as a flexible contracting vehicle allowing AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Exforge, an antihypertensive medication combining amlodipine and valsartan, falls within the extensive therapeutic domains covered under the prime vendor agreement for military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/17/25 |